Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel
NASDAQ:MYSZ

My Size Q1 2025 Earnings Report

My Size logo
$1.88 +0.20 (+11.90%)
As of 09/23/2026 04:00 PM Eastern
ProfileEarnings HistoryForecast

My Size EPS Results

Actual EPS
-$4.08
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

My Size Revenue Results

Actual Revenue
$1.48 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

My Size Announcement Details

Quarter
Q1 2025
Date
5/15/2025
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

My Size's next earnings date is estimated for Wednesday, November 18, 2026, based on past reporting schedules.

Conference Call Resources

My Size Earnings Headlines

Head-To-Head Review: My Size (NASDAQ:MYSZ) vs. RealReal (NASDAQ:REAL)
September 22 at 5:29 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=31039227
MySize Announces $2.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
September 15, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/mysize-announces-2-5-million-private-placement-priced-at-the-market-under-nasdaq-rules-302879730.html
Elon gets it. Do you?
Moderna's stock jumped nearly 200% in a single day after a successful Phase 3 trial for its cancer drug, and Merck added $43 billion to its market cap on the same news. Porter & Co. says AI-driven drug discovery and automated labs are cutting development timelines by up to 80% and lifting early clinical success rates to 90%, fueling what they call biotech's Ignition Point.tc pixel
September 24 at 1:00 AM  |  Porter & Company (Ad)
MySize Announces Acquisition-Led Strategy Focused on Defense Technology
September 14, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/mysize-announces-acquisition-led-strategy-focused-on-defense-technology-302877533.html
My Size Receives Nasdaq Notice Over Equity Listing Compliance
August 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/my-size-receives-nasdaq-notice-over-equity-listing-compliance?utm_source=marketbeat.com&utm_medium=referral
MySize's Naiz Fit Surpasses 500 Million Size Recommendations as AI Fashion Platform Expands Into Virtual Try-On
August 18, 2026  |  prnewswire.comhttps://www.prnewswire.com/news-releases/mysizes-naiz-fit-surpasses-500-million-size-recommendations-as-ai-fashion-platform-expands-into-virtual-try-on-302854072.html
See More My Size Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like My Size? Sign up for Earnings360's daily newsletter to receive timely earnings updates on My Size and other key companies, straight to your email.

About My Size

My Size (NASDAQ:MYSZ) is a technology company focused on digital sizing and fit solutions for the apparel and e-commerce industries. Its technology is designed to help consumers determine appropriate clothing sizes and improve the online shopping experience while helping retailers reduce fit-related returns.

The company’s principal product, MySizeID, uses smartphone-based measurements and sizing data to generate personalized size recommendations. My Size has also developed tools intended to help apparel brands and retailers integrate sizing recommendations into their websites, mobile applications and other digital sales channels.

My Size was founded in Israel and has historically marketed its solutions to apparel retailers, brands and consumers in international markets. The company has also expanded its product capabilities through technology development and business combinations, including the addition of fit and sizing-related solutions. Ronen Luzon has served as the company’s chief executive officer and has been associated with its leadership since its early development.

View My Size Profile
Earnings Tools